EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Cancer-cell-derived cGAMP limits the activity of tumor-associated CD8+ T cells

Michael Herbst, Hakan Köksal, Silvan Brunn, Dominik Zanetti, Ioana Domocos, Viola De Stefani, Marco Gatti, Francesca Vivalda, Paulo Pereira, Marc Nater, Virginia Cecconi, Alessandro A Sartori und 1 weitere

Cell Reports · 2025

DOI: 10.1016/j.celrep.2025.115510 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cell Reports, 2025. Verfasst von Michael Herbst und 12 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Experimental Immunology, University of Zurich, Zurich, Switzerland. Hauptthemen laut MEDLINE: CD8-Positive T-Lymphocytes, Nucleotides, Cyclic, Neoplasms. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 82 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: University of Zurich, Novartis Foundation for Medical-Biological Research, Swiss National Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CD8-Positive T-LymphocytesNucleotides, CyclicNeoplasmsAnimalsMiceMembrane ProteinsTumor MicroenvironmentMice, Inbred C57BLCell Line, TumorSignal TransductionNucleotidyltransferasesInterferon Type ICell ProliferationHumansSTING Protein

Stichwörter der Autor:innen

CD8(+)CP: CancerCP: ImmunologySTINGT cellscGAMPcGAScancerimmunitytumor microenvironment

Substanzen

Nucleotides, CyclicMembrane ProteinsNucleotidyltransferasesInterferon Type Icyclic guanosine monophosphate-adenosine monophosphateSting1 protein, mouseSTING Protein

Autor:innen und Institutionen

  • Institute of Experimental Immunology, University of Zurich, Zurich, Switzerland.
  • Institute of Molecular Cancer Research, University of Zurich, Zurich, Switzerland.
  • Institute of Experimental Immunology, University of Zurich, Zurich, Switzerland. Electronic address: maries.vandenbroek@uzh.ch.

Förderung

  • University of Zurich
  • Novartis Foundation for Medical-Biological Research
  • Swiss National Science Foundation
  • Hartmann Müller Foundation for Medical Research
  • Johannes Gutenberg-Universität Mainz

Zitieren

APA

Herbst, M., Köksal, H., Brunn, S., Zanetti, D., Domocos, I., De Stefani, V., Gatti, M., Vivalda, F., Pereira, P., Nater, M., Cecconi, V., Sartori, A. A., & van den Broek, M. (2025). Cancer-cell-derived cGAMP limits the activity of tumor-associated CD8+ T cells. Cell Reports. https://doi.org/10.1016/j.celrep.2025.115510

Vancouver

Herbst M, Köksal H, Brunn S, Zanetti D, Domocos I, De Stefani V, et al. Cancer-cell-derived cGAMP limits the activity of tumor-associated CD8+ T cells. Cell Reports. 2025. doi:10.1016/j.celrep.2025.115510

BibTeX
@article{Herbst2025,
  author = {Herbst, Michael and Köksal, Hakan and Brunn, Silvan and Zanetti, Dominik and Domocos, Ioana and De Stefani, Viola and Gatti, Marco and Vivalda, Francesca and Pereira, Paulo and Nater, Marc and Cecconi, Virginia and Sartori, Alessandro A and van den Broek, Maries},
  title = {Cancer-cell-derived cGAMP limits the activity of tumor-associated CD8+ T cells},
  journal = {Cell Reports},
  year = {2025},
  doi = {10.1016/j.celrep.2025.115510}
}
Kostenlos starten →